Interferon, Mx, and viral countermeasures

Cytokine and Growth Factor Reviews

Volumn 18, Issue 5-6, 2007, Pages 425-433

  Haller, Otto ^a   Kochs, Georg ^a   Weber, Friedemann ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Interferon; Interferon antagonists; Interferon stimulated gene products; Mx; Viral countermeasures

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; BETA INTERFERON; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYTOKINE; GUANOSINE TRIPHOSPHATASE; INTERFERON; INTERLEUKIN 28A; INTERLEUKIN 28B; INTERLEUKIN 29; MYXOVIRUS RESISTANCE PROTEIN; PATTERN RECOGNITION RECEPTOR; PROTEIN KINASE R; RECOMBINANT PROTEIN; RIBONUCLEASE L; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; GENE EXPRESSION; HUMAN; INFLUENZA VIRUS A; INTERFERON PRODUCTION; MOUSE STRAIN; NONHUMAN; ORTHOMYXOVIRUS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; GTP-BINDING PROTEINS; INTERFERONS; VIRUSES;

MUS;

EID: 34548119875     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2007.06.001     Document Type: Article

References (132)

1. Guenet J.L., and Bonhomme F. Wild mice: an ever-increasing contribution to a popular mammalian model. Trends Genet 19 (2003) 24-31
2. Haller O. Inborn resistance of mice to orthomyxoviruses. Curr Top Microbiol Immunol 92 (1981) 25-52
3. Haller O., Acklin M., and Staeheli P. Influenza virus resistance of wild mice: wild-type and mutant Mx alleles occur at comparable frequencies. J Interferon Res 7 (1987) 647-656
4. Lindenmann J. Resistance of mice to mouse-adapted influenza A virus. Virology 16 (1962) 203-204
5. Reeves R.H., O'Hara B.F., Pavan W.J., Gearhart J.D., and Haller O. Genetic mapping of the Mx influenza virus resistance gene within the region of mouse chromosome 16 that is homologous to human chromosome 21. J Virol 62 (1988) 4372-4375
6. Arnheiter H., Skuntz S., Noteborn M., Chang S., and Meier E. Transgenic mice with intracellular immunity to influenza virus. Cell 62 (1990) 51-61
7. Staeheli P., Haller O., Boll W., Lindenmann J., and Weissmann C. Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell 44 (1986) 147-158
8. Haller O., Arnheiter H., Lindenmann J., and Gresser I. Host gene influences sensitivity to interferon action selectively for influenza virus. Nature 283 (1980) 660-662
9. Holzinger D., Jorns C., Stertz S., et al. Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J Virol 81 (2007) 7776-7785
10. Antonelli G., Simeoni E., Turriziani O., et al. Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-alpha therapy. J Interferon Cytokine Res 19 (1999) 243-251
11. Roers A., Hochkeppel H.K., Horisberger M.A., Hovanessian A., and Haller O. MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon. J Infect Dis 169 (1994) 807-813
12. Staeheli P., Grob R., Meier E., Sutcliffe J.G., and Haller O. Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol Cell Biol 8 (1988) 4518-4523
13. Perelygin A.A., Scherbik S.V., Zhulin I.B., Stockman B.M., Li Y., and Brinton M.A. Positional cloning of the murine flavivirus resistance gene. Proc Natl Acad Sci USA 99 (2002) 9322-9327
14. Mashimo T., Lucas M., Simon-Chazottes D., et al. A nonsense mutation in the gene encoding 2′-5′-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc Natl Acad Sci USA 99 (2002) 11311-11316
15. Brinton M.A., and Perelygin A.A. Genetic resistance to flaviviruses. Adv Virus Res 60 (2003) 43-85
16. Casanova J.L., Schurr E., Abel L., and Skamene E. Forward genetics of infectious diseases: immunological impact. Trends Immunol 23 (2002) 469-472
17. van Pesch V., Lanaya H., Renauld J.C., and Michiels T. Characterization of the murine alpha interferon gene family. J Virol 78 (2004) 8219-8228
18. Roberts R.M., Ezashi T., Rosenfeld C.S., Ealy A.D., and Kubisch H.M. Evolution of the interferon tau genes and their promoters, and maternal-trophoblast interactions in control of their expression. Reprod Suppl 61 (2003) 239-251
19. Ank N., West H., and Paludan S.R. IFN-lambda: novel antiviral cytokines. J Interferon Cytokine Res 26 (2006) 373-379
20. Weber F., Wagner V., Rasmussen S.B., Hartmann R., and Paludan S.R. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol 80 (2006) 5059-5064
21. Hornung V., Ellegast J., Kim S., et al. 5′-Triphosphate RNA Is the ligand for RIG-I. Science 314 (2006) 994-997
22. Pichlmair A., Schulz O., Tan C.P., et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′ phosphates. Science 314 (2006) 997-1001
23. Bowie A.G., and Fitzgerald K.A. RIG-I: tri-ing to discriminate between self and non-self RNA. Trends Immunol 28 (2007) 147-150
24. Hiscott J. Triggering the innate antiviral response through IRF-3 activation. J Biol Chem 282 (2007) 15325-15329
25. Fitzgerald K.A., McWhirter S.M., Faia K.L., et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4 (2003) 491-496
26. Sharma S., TenOever B.R., Grandvaux N., Zhou G.P., Lin R., and Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science 300 (2003) 1148-1151
27. Andrejeva J., Childs K.S., Young D.F., et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci USA 101 (2004) 17264-17269
28. Yoneyama M., Kikuchi M., Natsukawa T., et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5 (2004) 730-737
29. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430 (2004) 257-263
30. Uematsu S., and Akira S. Toll-like receptors and type I interferons. J Biol Chem 282 (2007) 15319-15323
31. tenOever B.R., Sharma S., Zou W., et al. Activation of TBK1 and IKK epsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity. J Virol 78 (2004) 10636-10649
32. Levy D.E., Marie I., and Prakash A. Ringing the interferon alarm: differential regulation of gene expression at the interface between innate and adaptive immunity. Curr Opin Immunol 15 (2003) 52-58
33. Honda K., and Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6 (2006) 644-658
34. Kawai T., Sato S., Ishii K.J., et al. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol (2004)
35. Levy D.E., and Darnell Jr. J.E. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3 (2002) 651-662
36. de Veer M.J., Holko M., Frevel M., et al. Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 69 (2001) 912-920
37. Der S.D., Zhou A., Williams B.R., and Silverman R.H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA 95 (1998) 15623-15628
38. Garcia M.A., Gil J., Ventoso I., et al. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev 70 (2006) 1032-1060
39. Williams B.R. PKR; a sentinel kinase for cellular stress. Oncogene 18 (1999) 6112-6120
40. Silverman R.H. Fascination with 2-5A-dependent RNase: a unique enzyme that functions in interferon action. J Interferon Res 14 (1994) 101-104
41. Haller O., and Kochs G. Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity. Traffic 3 (2002) 710-717
42. Zhou A., Paranjape J., Brown T.L., et al. Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate-dependent RNase L. EMBO J 16 (1997) 6355-6363
43. Zhou A., Paranjape J.M., Der S.D., Williams B.R., and Silverman R.H. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology 258 (1999) 435-440
44. Espert L., Degols G., Gongora C., et al. ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses. J Biol Chem 278 (2003) 16151-16158
45. Guo J., Hui D.J., Merrick W.C., and Sen G.C. A new pathway of translational regulation mediated by eukaryotic initiation factor 3. EMBO J 19 (2000) 6891-6899
46. Hui D.J., Bhasker C.R., Merrick W.C., and Sen G.C. Viral stress-inducible protein p56 inhibits translation by blocking the interaction of eIF3 with the ternary complex eIF2.GTP.Met-tRNAi. J Biol Chem 278 (2003) 39477-39482
47. Anderson S.L., Carton J.M., Lou J., Xing L., and Rubin B.Y. Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus. Virology 256 (1999) 8-14
48. Regad T., and Chelbi-Alix M.K. Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene 20 (2001) 7274-7286
49. Wang C., Pflugheber J., Sumpter Jr. R., et al. Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication. J Virol 77 (2003) 3898-3912
50. Chelbi-Alix M.K., Quignon F., Pelicano L., Koken M.H., and de The H. Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J Virol 72 (1998) 1043-1051
51. Djavani M., Rodas J., Lukashevich I.S., et al. Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus. J Virol 75 (2001) 6204-6208
52. Regad T., Saib A., Lallemand-Breitenbach V., Pandolfi P.P., de The H., and Chelbi-Alix M.K. PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO J 20 (2001) 3495-3505
53. Chee A.V., Lopez P., Pandolfi P.P., and Roizman B. Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J Virol 77 (2003) 7101-7105
54. Engelhardt O.G., Sirma H., Pandolfi P.P., and Haller O. Mx1 GTPase accumulates in distinct nuclear domains and inhibits influenza A virus in cells that lack promyelocytic leukaemia protein nuclear bodies. J Gen Virol 85 (2004) 2315-2326
55. Arnheiter H., Frese M., Kambadur R., Meier E., and Haller O. Mx transgenic mice-animal models of health. Curr Top Microbiol Immunol 206 (1996) 119-147
56. Kochs G., and Haller O. Interferon-induced human MxA GTPase blocks nuclear import of Thogoto virus nucleocapsids. Proc Natl Acad Sci USA 96 (1999) 2082-2086
57. Kochs G., Janzen C.H., Hohenberg H., and Haller O. Antivirally active MxA protein sequesters LaCrosse virus nucleocapsid protein into perinuclear complexes. Proc Natl Acad Sci USA 99 (2002) 3153-3158
58. Reichelt M., Stertz S., Krijnse-Locker J., Haller O., and Kochs G. Missorting of LaCrosse virus nucleocapsid protein by the interferon-induced MxA GTPase involves smooth ER membranes. Traffic 5 (2004) 772-784
59. Hefti H.P., Frese M., Landis H., et al. Human MxA protein protects mice lacking a functional alpha/beta interferon system against LaCrosse virus and other lethal viral infections. J Virol 73 (1999) 6984-6991
60. Alcami A., and Smith G.L. Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J Virol 69 (1995) 4633-4639
61. Alcami A., Symons J.A., and Smith G.L. The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J Virol 74 (2000) 11230-11239
62. Puehler F., Weining K.C., Symons J.A., Smith G.L., and Staeheli P. Vaccinia virus-encoded cytokine receptor binds and neutralizes chicken interferon-gamma. Virology 248 (1998) 231-240
63. Symons J.A., Alcami A., and Smith G.L. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81 (1995) 551-560
64. Garcia-Sastre A., and Biron C.A. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312 (2006) 879-882
65. Haller O., Kochs G., and Weber F. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344 (2006) 119-130
66. Hengel H., Koszinowski U.H., and Conzelmann K.K. Viruses know it all: new insights into IFN networks. Trends Immunol 26 (2005) 396-401
67. Mibayashi M., Martinez-Sobrido L., Loo Y.M., Cardenas W.B., Gale Jr. M., and Garcia-Sastre A. Inhibition of retinoic acid-inducible gene-I-mediated induction of interferon-{beta} by the NS1 protein of influenza A virus. J Virol 81 (2007) 514-524
68. Childs K., Stock N., Ross C., et al. Mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 359 (2007) 190-200
69. Kawai T., Takahashi K., Sato S., et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6 (2005) 981-988
70. Meylan E., Curran J., Hofmann K., et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437 (2005) 1167-1172
71. Seth R.B., Sun L., Ea C.K., and Chen Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF3. Cell 122 (2005) 669-682
72. Xu L.G., Wang Y.Y., Han K.J., Li L.Y., Zhai Z., and Shu H.B. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19 (2005) 1-14
73. Chen Z., Benureau Y., Rijnbrand R., et al. GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS. J Virol 81 (2007) 964-976
74. Lin R., Lacoste J., Nakhaei P., et al. Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J Virol 80 (2006) 6072-6083
75. Brzozka K., Finke S., and Conzelmann K.K. Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J Virol 79 (2005) 7673-7681
76. Alff P.J., Gavrilovskaya I.N., Gorbunova E., et al. The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J Virol 80 (2006) 9676-9686
77. Bauhofer O., Summerfield A., McCullough K.C., and Ruggli N. Role of double-stranded RNA and Npro of classical swine fever virus in the activation of monocyte-derived dendritic cells. Virology 343 (2005) 93-105
78. La Rocca S.A., Herbert R.J., Crooke H., Drew T.W., Wileman T.E., and Powell P.P. Loss of interferon regulatory factor 3 in cells infected with classical swine fever virus involves the N-terminal protease, Npro. J Virol 79 (2005) 7239-7247
79. Ruggli N., Bird B.H., Liu L., Bauhofer O., Tratschin J.D., and Hofmann M.A. N(pro) of classical swine fever virus is an antagonist of double-stranded RNA-mediated apoptosis and IFN-alpha/beta induction. Virology 340 (2005) 265-276
80. Bauhofer O, Summerfield A, Sakoda Y, Tratschin JD, Hofmann MA, Ruggli N. Npro of classical swine fever virus interacts with interferon regulatory factor 3 and induces its proteasomal degradation. J Virol 2007; in press.
81. Hilton L., Moganeradj K., Zhang G., et al. The NPro product of bovine viral diarrhea virus inhibits DNA binding by interferon regulatory factor 3 and targets it for proteasomal degradation. J Virol 80 (2006) 11723-11732
82. Ronco L.V., Karpova A.Y., Vidal M., and Howley P.M. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 12 (1998) 2061-2072
83. Kopecky-Bromberg S.A., Martinez-Sobrido L., Frieman M., Baric R.A., and Palese P. Sars coronavirus proteins Orf 3b, Orf 6, and nucleocapsid function as interferon antagonists. J Virol 81 (2007) 548-557
84. Spiegel M., Pichlmair A., Martinez-Sobrido L., et al. Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J Virol 79 (2005) 2079-2086
85. Burysek L., Yeow W.S., Lubyova B., et al. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J Virol 73 (1999) 7334-7342
86. Burysek L., Yeow W.S., and Pitha P.M. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2). J Hum Virol 2 (1999) 19-32
87. Fuld S., Cunningham C., Klucher K., Davison A.J., and Blackbourn D.J. Inhibition of interferon signaling by the Kaposi's sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein. J Virol 80 (2006) 3092-3097
88. Li M., Lee H., Guo J., et al. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor. J Virol 72 (1998) 5433-5440
89. Lubyova B., and Pitha P.M. Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors. J Virol 74 (2000) 8194-8201
90. Lubyova B., Kellum M.J., Frisancho A.J., and Pitha P.M. Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7. J Biol Chem 279 (2004) 7643-7654
91. Zimring J.C., Goodbourn S., and Offermann M.K. Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J Virol 72 (1998) 701-707
92. Bouloy M., Janzen C., Vialat P., et al. Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J Virol 75 (2001) 1371-1377
93. Billecocq A., Spiegel M., Vialat P., et al. NSs protein of Rift Valley Fever Virus blocks interferon production by inhibiting host gene transcription. J. Virol. 78 (2004) 9798-9806
94. Le May N., Dubaele S., De Santis L.P., Billecocq A., Bouloy M., and Egly J.M. TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 116 (2004) 541-550
95. Thomas D., Blakqori G., Wagner V., et al. Inhibition of RNA polymerase II phosphorylation by a viral interferon antagonist. J Biol Chem 279 (2004) 31471-31477
96. Cardenas W.B., Loo Y.M., Gale Jr. M., et al. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J Virol 80 (2006) 5168-5178
97. Child S.J., Hanson L.K., Brown C.E., Janzen D.M., and Geballe A.P. Double-stranded RNA binding by a heterodimeric complex of murine cytomegalovirus m142 and m143 proteins. J Virol 80 (2006) 10173-10180
98. Garcia-Sastre A., Egorov A., Matassov D., et al. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252 (1998) 324-330
99. Garcia-Sastre A. Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. Virology 279 (2001) 375-384
100. Hartman A.L., Dover J.E., Towner J.S., and Nichol S.T. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication. J Virol 80 (2006) 6430-6440
101. Langland J.O., Cameron J.M., Heck M.C., Jancovich J.K., and Jacobs B.L. Inhibition of PKR by RNA and DNA viruses. Virus Res 119 (2006) 100-110
102. Lee T.G., Tomita J., Hovanessian A.G., and Katze M.G. Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells. Proc Natl Acad Sci USA 87 (1990) 6208-6212
103. Valchanova R.S., Picard-Maureau M., Budt M., and Brune W. Murine cytomegalovirus m142 and m143 are both required to block protein kinase R-mediated shutdown of protein synthesis. J Virol 80 (2006) 10181-10190
104. Mathews M.B., and Shenk T. Adenovirus virus-associated RNA and translation control. J Virol 65 (1991) 5657-5662
105. Vyas J., Elia A., and Clemens M.J. Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA. RNA 9 (2003) 858-870
106. Elia A., Laing K.G., Schofield A., Tilleray V.J., and Clemens M.J. Regulation of the double-stranded RNA-dependent protein kinase PKR by RNAs encoded by a repeated sequence in the Epstein-Barr virus genome. Nucleic Acids Res 24 (1996) 4471-4478
107. Gunnery S., Rice A.P., Robertson H.D., and Mathews M.B. Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase. Proc Natl Acad Sci USA 87 (1990) 8687-8691
108. He B., Gross M., and Roizman B. The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 94 (1997) 843-848
109. Taylor D.R., Shi S.T., Romano P.R., Barber G.N., and Lai M.M. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285 (1999) 107-110
110. Roy S., Katze M.G., Parkin N.T., Edery I., Hovanessian A.G., and Sonenberg N. Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science 247 (1990) 1216-1219
111. Davies M.V., Elroy-Stein O., Jagus R., Moss B., and Kaufman R.J. The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J Virol 66 (1992) 1943-1950
112. Li S., Min J.Y., Krug R.M., and Sen G.C. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 349 (2006) 13-21
113. Min J.Y., and Krug R.M. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci USA 103 (2006) 7100-7105
114. Black T.L., Barber G.N., and Katze M.G. Degradation of the interferon-induced 68,000-M(r) protein kinase by poliovirus requires RNA. J Virol 67 (1993) 791-800
115. Martinand C., Montavon C., Salehzada T., Silhol M., Lebleu B., and Bisbal C. RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells. J Virol 73 (1999) 290-296
116. Martinand C., Salehzada T., Silhol M., Lebleu B., and Bisbal C. RNase L inhibitor (RLI) antisense constructions block partially the down regulation of the 2-5A/RNase L pathway in encephalomyocarditis-virus-(EMCV)-infected cells. Eur J Biochem 254 (1998) 248-255
117. Cayley P.J., Davies J.A., McCullagh K.G., and Kerr I.M. Activation of the ppp(A2′p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2′p)nA-dependent RNase. Eur J Biochem 143 (1984) 165-174
118. Han J.Q., Townsend H.L., Jha B.K., Paranjape J.M., Silverman R.H., and Barton D.J. A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L. J Virol 81 (2007) 5561-5572
119. Atreya P.L., and Kulkarni S. Respiratory syncytial virus strain A2 is resistant to the antiviral effects of type I interferons and human MxA. Virology 261 (1999) 227-241
120. Young D.F., Didcock L., Goodbourn S., and Randall R.E. Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. Virology 269 (2000) 383-390
121. Schlender J., Bossert B., Buchholz U., and Conzelmann K.K. Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response. J Virol 74 (2000) 8234-8242
122. Spann K.M., Tran K.C., Chi B., Rabin R.L., and Collins P.L. Suppression of the induction of alpha, beta, and gamma interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages. J Virol 78 (2004) 4363-4369
123. Wright P.F., Karron R.A., Madhi S.A., et al. The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans. J Infect Dis 193 (2006) 573-581
124. Moller A., and Schmitz M.L. Viruses as hijackers of PML nuclear bodies. Arch Immunol Ther Exp (Warsz) 51 (2003) 295-300
125. Boutell C., Sadis S., and Everett R.D. Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro. J Virol 76 (2002) 841-850
126. Van Sant C., Hagglund R., Lopez P., and Roizman B. The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity. Proc Natl Acad Sci USA 98 (2001) 8815-8820
127. Muller S., and Dejean A. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. J Virol 73 (1999) 5137-5143
128. Kochs G., Weber F., Gruber S., Delvendahl A., Leitz C., and Haller O. Thogoto virus matrix protein is encoded by a spliced mRNA. J Virol 74 (2000) 10785-10789
129. Hagmaier K., Jennings S., Buse J., Weber F., and Kochs G. Novel gene product of Thogoto virus segment 6 codes for an interferon antagonist. J Virol 77 (2003) 2747-2752
130. Pichlmair A., Buse J., Jennings S., Haller O., Kochs G., and Staeheli P. Thogoto virus lacking interferon-antagonistic protein ML is strongly attenuated in newborn Mx1-positive but not Mx1-negative mice. J Virol 78 (2004) 11422-11424
131. Grimm D., Staeheli P., Hufbauer M., et al. Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene. Proc Natl Acad Sci USA 104 (2007) 6806-6811
132. Jennings S., Martinez-Sobrido L., Garcia-Sastre A., Weber F., and Kochs G. Thogoto virus ML protein suppresses IRF3 function. Virology 331 (2005) 63-72